- Home
- MYGN vs FFWM Comparison
MYGN vs FFWM Comparison
Compare MYGN & FFWM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYGN
- FFWM
- Stock Information
- Founded
- MYGN 1991
- FFWM 1990
- Country
- MYGN United States
- FFWM United States
- Employees
- MYGN N/A
- FFWM N/A
- Industry
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- FFWM Major Banks
- Sector
- MYGN Health Care
- FFWM Finance
- Exchange
- MYGN Nasdaq
- FFWM Nasdaq
- Market Cap
- MYGN 423.1M
- FFWM 406.2M
- IPO Year
- MYGN 1995
- FFWM 2014
- Fundamental
- Price
- MYGN $6.02
- FFWM $5.85
- Analyst Decision
- MYGN Hold
- FFWM Buy
- Analyst Count
- MYGN 13
- FFWM 2
- Target Price
- MYGN $13.50
- FFWM $6.25
- AVG Volume (30 Days)
- MYGN 2.4M
- FFWM 990.3K
- Earning Date
- MYGN 08-05-2025
- FFWM 07-31-2025
- Dividend Yield
- MYGN N/A
- FFWM N/A
- EPS Growth
- MYGN N/A
- FFWM N/A
- EPS
- MYGN N/A
- FFWM N/A
- Revenue
- MYGN $832,900,000.00
- FFWM $104,325,000.00
- Revenue This Year
- MYGN N/A
- FFWM $164.53
- Revenue Next Year
- MYGN $6.64
- FFWM $9.97
- P/E Ratio
- MYGN N/A
- FFWM N/A
- Revenue Growth
- MYGN 3.83
- FFWM N/A
- 52 Week Low
- MYGN $3.76
- FFWM $4.42
- 52 Week High
- MYGN $29.30
- FFWM $8.52
- Technical
- Relative Strength Index (RSI)
- MYGN 62.34
- FFWM 67.68
- Support Level
- MYGN $5.23
- FFWM $5.30
- Resistance Level
- MYGN $6.07
- FFWM $5.45
- Average True Range (ATR)
- MYGN 0.39
- FFWM 0.21
- MACD
- MYGN 0.05
- FFWM 0.07
- Stochastic Oscillator
- MYGN 81.27
- FFWM 100.00
About MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.
About FFWM First Foundation Inc.
First Foundation Inc is a financial services company. It is engaged in providing investment management and financial planning services for high-net-worth individuals, retirement plans, charitable institutions, and private foundations. The company focuses on segments namely Banking and Wealth Management. It also offers loans to individuals and entities that own and operate multifamily residential and commercial real estate properties as well as business banking products and services to small to moderate-sized businesses, professional firms, and consumer banking products and services to individuals.